Pages that link to "Q71353250"
Jump to navigation
Jump to search
The following pages link to Midbrain dopaminergic neurons in the mouse: computer-assisted mapping (Q71353250):
Displaying 50 items.
- Dopamine neuron systems in the brain: an update (Q22251429) (← links)
- Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease (Q27334826) (← links)
- Diversity matters - heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson's Disease (Q28078561) (← links)
- 'Rejuvenation' protects neurons in mouse models of Parkinson's disease (Q28305585) (← links)
- Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons (Q28343155) (← links)
- Spontaneous circling behavior and dopamine neuron loss in a genetically hypothyroid mouse (Q28512718) (← links)
- The role of dopamine receptors in regulating the size of axonal arbors (Q28591256) (← links)
- Kv3-Like Potassium Channels Are Required for Sustained High-Frequency Firing in Basal Ganglia Output Neurons (Q30498803) (← links)
- An ultra-short dopamine pathway regulates basal ganglia output (Q30537551) (← links)
- Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons (Q31673344) (← links)
- Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation (Q34130806) (← links)
- Molecular and functional differences in voltage-activated sodium currents between GABA projection neurons and dopamine neurons in the substantia nigra (Q35602384) (← links)
- Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease (Q38637523) (← links)
- Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice. (Q36176040) (← links)
- Estrogen and the development and protection of nigrostriatal dopaminergic neurons: concerted action of a multitude of signals, protective molecules, and growth factors (Q36583912) (← links)
- The pars reticulata of the substantia nigra: a window to basal ganglia output (Q36820592) (← links)
- A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL/6J mouse (Q37248811) (← links)
- Molecular Diversity of Midbrain Development in Mouse, Human, and Stem Cells (Q37320970) (← links)
- Treadmill exercise ameliorates impairment of spatial learning ability through enhancing dopamine expression in hypoxic ischemia brain injury in neonatal rats (Q37332387) (← links)
- Vasopressin innervation of the mouse (Mus musculus) brain and spinal cord (Q37610864) (← links)
- Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update (Q38310102) (← links)
- Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation (Q38495363) (← links)
- Direct differentiation of adult ocular progenitors into striatal dopaminergic neurons (Q41154991) (← links)
- An optimized method for counting dopaminergic neurons in zebrafish. (Q41570995) (← links)
- PACAP27 prevents Parkinson-like neuronal loss and motor deficits but not microglia activation induced by prostaglandin J2. (Q41769727) (← links)
- Kinetics of nigral degeneration in a chronic model of MPTP-treated mice (Q42446048) (← links)
- Differential strain susceptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus. (Q42471915) (← links)
- Patterns of axonal branching of neurons of the substantia nigra pars reticulata and pars lateralis in the rat. (Q42485169) (← links)
- Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons. (Q43863231) (← links)
- Differential expression of AMPA receptor subunits in dopamine neurons of the rat brain: a double immunocytochemical study. (Q43742982) (← links)
- The role of interleukin-1, interleukin-6, and glia in inducing growth of neuronal terminal arbors in mice. (Q44132588) (← links)
- Effects of long-term treatment with dopamine receptor agonists and antagonists on terminal arbor size. (Q44173422) (← links)
- Tau Deficiency Down-Regulated Transcription Factor Orthodenticle Homeobox 2 Expression in the Dopaminergic Neurons in Ventral Tegmental Area and Caused No Obvious Motor Deficits in Mice (Q47862637) (← links)
- The weaver mouse gain-of-function phenotype of dopaminergic midbrain neurons is determined by coactivation of wvGirk2 and K-ATP channels (Q48093958) (← links)
- Characterization of dopaminergic midbrain neurons in a DBH:BDNF transgenic mouse (Q48102803) (← links)
- The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter (Q48474982) (← links)
- Mesencephalic dopaminergic neurons expressing neuromedin K receptor (NK3): a double immunocytochemical study in the rat. (Q48515121) (← links)
- Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway (Q48547124) (← links)
- Epigenetic cues in midbrain dopaminergic neuron development (Q51083158) (← links)
- Temporary inactivation of the retrorubral fields decreases the rewarding effect of medial forebrain bundle stimulation (Q51371464) (← links)
- A comprehensive map coupling histone modifications with gene regulation in adult dopaminergic and serotonergic neurons. (Q51415870) (← links)
- Cell Densities in the Mouse Brain: A Systematic Review (Q58573118) (← links)
- Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets (Q58714026) (← links)
- Chapter I The organization and circuits of mesencephalic dopaminergic neurons and the distribution of dopamine receptors in the brain (Q58852452) (← links)
- In vivo nuclear capture and molecular profiling identifies Gmeb1 as a transcriptional regulator essential for dopamine neuron function. (Q64900178) (← links)
- Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice (Q73515487) (← links)
- Monoaminergic Neuromodulation of Sensory Processing (Q90454187) (← links)
- Blockade of microglial Cav1.2 Ca2 channel exacerbates the symptoms in a Parkinson's disease model (Q93000143) (← links)
- Midbrain Dopaminergic Neuron Development at the Single Cell Level: In vivo and in Stem Cells (Q98178390) (← links)
- Mesencephalic dopaminergic neurons expressing neuromedin K receptor (NK3): a double immunocytochemical study in the rat (Q131403981) (← links)